Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception

Area of Science:

• Reproductive Endocrinology
• Infertility Research
• Gynecology

Background:

• Rising infertility rates affect approximately 1 in 6 couples, necessitating assisted reproductive techniques (ART).
• Anti-Mullerian hormone (AMH), initially identified in embryonic development, plays a crucial role in folliculogenesis and ovarian reserve.
• Serum AMH assays, developed in the 1990s, are now integral to managing female fertility.

Purpose of the Study:

• To review the current understanding of Anti-Mullerian hormone (AMH) assessment in reproductive medicine.
• To evaluate the predictive value of AMH levels for spontaneous pregnancy.
• To analyze the role of AMH in predicting outcomes of assisted reproductive techniques (ART) and fertility preservation.

Main Methods:

• Literature review of studies on Anti-Mullerian hormone (AMH) in reproductive medicine.
• Analysis of AMH assay utility in predicting fertility outcomes.
• Focus on AMH's role in spontaneous conception, ART success rates, and fertility preservation.

Main Results:

• Serum AMH levels serve as a quantitative marker of ovarian reserve.
• AMH is widely utilized in managing women's fertility and guiding ART protocols.
• The hormone's predictive capacity for spontaneous pregnancy, ART outcomes, and fertility preservation is established.

Conclusions:

• Anti-Mullerian hormone (AMH) assessment is a vital tool in modern reproductive medicine.
• AMH levels provide crucial insights into a woman's reproductive potential.
• This review consolidates knowledge on AMH's application in fertility management and treatment success prediction.